Hao Han

Prof. Hao Han

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2013 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
PXPeng Xin
Peng Xin
HHHao Han
Hao Han
DGDanhong Gao
Danhong Gao
WCWei Cui
Wei Cui
XYXuefeng Yang
Xuefeng Yang
LHLiping Hao
Liping Hao

7 February 2015 in Lipids
Verified
Journal Article
Closed access
PDF file
HHHao Han
Hao Han
WCWei Cui
Wei Cui
LWLinzhi Wang
Linzhi Wang
YXYufang Xiong
Yufang Xiong
LLLiegang Liu
Liegang Liu
LHLiping Hao
Liping Hao

10 February 2021 in Food & Function
Verified
Journal Article
Closed access
PDF file
HHHao Han
Hao Han
XLXiaoyu Li
Xiaoyu Li
YGYan Guo
Yan Guo
MZMingming Zheng
Mingming Zheng
TXTingli Xue
Tingli Xue
LWLinqi Wang
Linqi Wang
The present study was designed to explore the beneficial mitochondrial effects and anti-oxidative activities of plant sterol ester of α-linolenic acid (PS-ALA) through AMP-activated protein kinase (AMPK) signaling in the treatment of nonalcoholic fatty liver disease (NAFLD) using in vivo and in vitro models. The mitochondrial function was evaluated and the oxidative stress index was measured. The protein expression was analyzed by immunohistochemical, immunofluorescence, and western blotting methods. The results showed that PS-ALA significantly suppressed NAFLD and alleviated steatosis in HepG2 cells induced by oleic acid (OA). In addition, PS-ALA promoted mitochondrial biogenesis, enhanced mitochondrial fatty acid oxidation capacity, improved mitochondrial dynamics, and restored mitochondrial membrane potential. Moreover, PS-ALA reduced reactive oxygen species production both in the liver tissue of HFD-fed mice and OA-loaded HepG2 cells. At the molecular level, PS-ALA accelerated the phosphorylation of AMPK and increased the protein expression of peroxisome proliferator-activated receptor-γ co-activator 1α (PGC-1α) and nuclear NF-E2-related factor 2 (Nrf2). Furthermore, the stimulating effects of PS-ALA on the PGC-1α/Nrf1/Tfam pathway and Nrf2/HO-1 pathway as well as its mitochondrial biogenesis promotion effects and anti-oxidative activities were abrogated by the AMPK inhibitor in OA-treated HepG2 cells. In conclusion, the protective effects of PS-ALA on NAFLD appear to be associated with improving mitochondrial function and oxidative stress via activating AMPK signaling.

1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
HHHao Han
Hao Han
FQFubin Qiu
Fubin Qiu
HZHaifeng Zhao
Haifeng Zhao
HTHaiying Tang
Haiying Tang
XLXiuhua Li
Xiuhua Li
DSDongxing Shi
Dongxing Shi
The prevalence of nonalcoholic fatty liver disease (NAFLD) has dramatically increased globally during recent decades. Intake of n‐3 polyunsaturated fatty acids (PUFAs), mainly eicosapentaenoic acid (EPA, C20:5n‐3) and docosahexaenoic acid (DHA, C22:6n‐3), is believed to be beneficial to the development of NAFLD. However, little information is available with regard to the effect of flaxseed oil rich in α‐linolenic acid (ALA, C18:3n‐3), a plant‐derived n‐3 PUFA, in improving NAFLD. This study was to gain the effect of flaxseed oil on NAFLD and further investigate the underlying mechanisms. Apolipoprotein‐E knockout (apoE‐KO) mice were given a normal chow diet, a western‐type high‐fat and high‐cholesterol diet (WTD), or a WTD diet containing 10% flaxseed oil (WTD + FO) for 12 weeks. Our data showed that consumption of flaxseed oil significantly improved WTD‐induced NAFLD, as well as ameliorated impaired lipid homeostasis, attenuated oxidative stress, and inhibited inflammation. These data were associated with the modification effects on expression levels of genes involved in de novo fat synthesis (SREBP‐1c, ACC), triacylglycerol catabolism (PPARα, CPT1A, and ACOX1), inflammation (NF‐κB, IL‐6, TNF‐α, and MCP‐1), and oxidative stress (ROS, MDA, GSH, and SOD).

6 January 2012 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
HHHao Han
Hao Han
PXPeng Xin
Peng Xin
LZLina Zhao
Lina Zhao
JXJian Xu
Jian Xu
YXYun Xia
Yun Xia
LHLiping Hao
Liping Hao

12 December 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
HHHao Han
Hao Han
YGYan Guo
Yan Guo
XLXiaoyu Li
Xiaoyu Li
DSDongxing Shi
Dongxing Shi
TXTingli Xue
Tingli Xue
MZMingming Zheng
Mingming Zheng
Nonalcoholic fatty liver disease (NAFLD) is becoming more common in the world and is presenting a great challenge concerning prevention and treatment. Plant sterol ester of α-linolenic acid (PS-ALA) has a potential benefit to NAFLD. To examine the effect of PS-ALA on NAFLD, C57BL/6J mice were given a control diet, high fat and high cholesterol diet (HFD), and HFD plus 2% PS, 1.3% ALA, or 3.3% PS-ALA for 16 weeks. Our results showed that PS-ALA treatment suppressed hepatic steatosis, ameliorated lipid disorder, attenuated inflammatory response, and inhibited oxidative stress. In the molecular level, PS-ALA downregulated high transcriptional and translational levels of endoplasmic reticulum (ER) stress markers (Grp78 and Chop) leading to decreased protein expression of transcription factor and key enzymes involved in de novo lipogenesis (Srebp-1c and Fas) and cholesterol synthesis (Srebp-2 and Hmgcr). In parallel, PS-ALA blocked Nlrp3 activation and reduced release of IL-1β and IL-18 via inhibiting ER stress-induced sensitization of unfolded protein response sensors (Ire1α and Xbp1s). Finally, PS-ALA improved HFD-induced mitochondrial damage and fatty acid accumulation as exhibited by higher protein and mRNA expression of key genes administering mitochondrial biogenesis (Pgc-1α, Nrf1, and Tfam) and fatty acid β-oxidation (Pparα and Cpt1a). In conclusion, our study originally demonstrated that PS-ALA rescued ER stress, enhanced mitochondrial biogenesis, and thus ameliorated NAFLD.